There are so many indications which SOME body should be working on. But GALT won’t have the money for years. Apparently there’s still no other corporate interest on what GALT has to offer. Chiles is no longer working GALT on cancer. (Maybe that’s good; Chiles was too EFFING slow) Phase 2b/3 for NASH might be done in … 2027 ?
Volume is back down to the trickle of 3 years ago. I see a possible 6 years of downward drifting share price.
News 
Market Data 
Discover 
